Wait, not so fast. Are the new American Heart Association endocarditis prophylaxis guidelines safe, and where is the proof?
- PMID: 20190899
- PMCID: PMC2690548
- DOI: 10.1093/pch/14.3.173
Wait, not so fast. Are the new American Heart Association endocarditis prophylaxis guidelines safe, and where is the proof?
References
-
- Hoffman JI, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol. 2002;39:1890–900. - PubMed
-
- Wilson W, Taubert KA, Gewitz M, et al. American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee; American Heart Association Council on Cardiovascular Disease in the Young; American Heart Association Council on Clinical Cardiology; American Heart Association Council on Cardiovascular Surgery and Anesthesia; Quality of Care and Outcomes Research Interdisciplinary Working Group. Prevention of infective endocarditis: Guidelines from the American Heart Association: A guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation. 2007;116:1736–54. (Erratum in 2007;116:e376–7) - PubMed
-
- van der Meer JT, Thompson J, Valkenburg HA, Michel MF. Epidemiology of bacterial endocarditis in the Netherlands. I. Patient characteristics. Arch Intern Med. 1992;52:1863–8. - PubMed
-
- Warnes C, Williams R, Bashore T, et al. ACC/AHA 2008 guidelines for the management of adults with congenital heart disease. J Am Coll Cardiol. 2008. pp. 143–263. < http://content.onlinejacc.org/cgi/content/full/j.jacc.2008.10.001> (Version current at January 23, 2009) - PubMed
LinkOut - more resources
Full Text Sources